Skip to main content

Table 2 The association between metabolic syndrome components and coronary heart disease

From: Effect of metabolic syndrome on coronary heart disease in rural minorities of Xinjiang: a retrospective cohort study

Components

N

CHD, n (%)

HR a (95% CI)

HR b (95% CI)

HR c (95% CI)

Large waistline

3583

202 (66.45)

2.23 (1.76–2.84)

1.42 (1.10–1.83)

1.28 (0.99–1.66)

High TG

1382

73 (24.01)

1.45 (1.11–1.89)

1.26 (0.97–1.64)

1.08 (0.82–1.41)

Low HDL-C

3661

152 (50.00)

1.04 (0.83–1.31)

1.07 (0.85–1.34)

1.07 (0.85–1.35)

Elevated blood pressure

3821

242 (79.61)

3.73 (2.82–4.93)

1.92 (1.44–2.58)

1.81 (1.35–2.44)

Elevated FBG

850

72 (23.68)

2.78 (2.14–3.63)

1.94 (1.49–2.54)

1.82 (1.38–2.38)

Metabolic syndrome

1963

148 (48.68)

2.99 (2.39–3.75)

1.81 (1.44–2.28)

–

  1. FBG fasting blood glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, CHD coronary heart disease, HR hazard ratios, CI confidence interval. Large waistline ≥ 90/80 cm; high TG ≥ 1.7 mmol/L; low HDL-C < 1.04/1.30 mmol/L; elevated blood pressure ≥ 130/85 mmHg; elevated FBG ≥ 5.6 mmol/L.
  2. a Without adjustment
  3. b Adjustment for alcohol consumption, smoking status, age, sex and family history of hypertension, family history of diabetes and family history of coronary heart disease
  4. c Adjustment for alcohol consumption, smoking status, age, sex and family history of hypertension, family history of diabetes and family history of coronary heart disease, and the other risk factors (i.e., large waistline, high TG, low HDL-C, elevated blood pressure and elevated FBG)